首頁 > 市場調查報告書 > 材料/化學品

化學品

市場調查報告書

商品編碼

1859731

全球生物基材料和生物製造市場：未來預測（至2032年）－按材料類型、生物製造方法、應用、最終用戶和地區進行分析

Bio-based Materials & Biofabrication Market Forecasts to 2032 - Global Analysis By Material Type (Bio-based Plastics, Bio-based Textiles, Bio-based Composites and Biofabrication Feedstocks), Biofabrication Method, Application, End User and By Geography

出版日期: 2025年11月01日 | 出版商:

Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，預計 2025 年全球生物基材料和生物製造市場規模將達到 150.9 億美元，到 2032 年將達到 331.5 億美元，預測期內複合年成長率為 11.9%。

生物基材料和生物製造技術正透過利用可再生生物資源生產永續且高效的產品，重塑材料開發格局。這些材料提取自植物、微生物和自然資源，憑藉其低排放和可生物分解性，為環境保護做出了貢獻。先進的生物製造方法，包括3D生物列印和組織工程，能夠促進醫療保健、包裝和建築等領域複雜結構的建造。生物學與工程學和材料科學的融合，催生了創新且環境友善的傳統材料替代方案。各產業對永續性的日益重視，推動了生物基材料和生物製造技術的投資、研究和實用化，成為全球轉型為更綠色解決方案的重要驅動力。

根據美國農業部 (USDA) 的生物優先計劃，超過 3500 種生物基產品已獲得聯邦採購認證，涵蓋潤滑劑、清潔劑、塑膠和建築材料等領域，這反映出機構對生物基替代品的需求日益成長。

不斷擴展的工業和醫療保健應用

醫療保健和工業領域對生物基材料和生物製造技術的日益普及，正推動著該市場的成長。組織工程、再生醫學和控釋藥物等醫療保健應用正在迅速擴展。同時，包裝、建築和紡織等行業也擴大使用生物基替代品，以實現永續性目標並滿足環保意識強的消費者的需求。生物基材料的生物分解性、功能性和多功能性使其在各種應用中更具吸引力。不斷成長的產業投資、戰略合作夥伴關係和合作研究計劃進一步推動了市場擴張。生物基材料和生物製造技術兼具環境效益和高性能，正成為全球醫療保健、製造業和消費品產業不可或缺的一部分。

原料供應有限

原料供應是生物基材料和生物製造市場面臨的主要挑戰。雖然許多原料來自植物、微生物和其他可再生資源，但其供應受季節性波動、農業生產力和土地競爭的影響。有限的供應鏈和區域依賴會導致成本增加和生產延誤。此外，將生產規模擴大到工業水平會增加自然資源的壓力，並引發永續性問題。這些因素可能會阻礙大規模生產，並減緩市場擴張。為確保永續成長，必須實施可靠、穩定且對環境負責的籌資策略，以應對供應鏈的脆弱性以及日益成長的生物基材料和生物製造產品的工業需求。

對永續產品的需求不斷成長

日益增強的環保意識和對永續實踐的推動，為生物基材料和生物製造創造了巨大的機會。在消費者需求和政府措施的驅動下，包裝、醫療保健、紡織和建築等行業正日益尋求可生物分解和環保的替代品。人們對氣候變遷影響的認知不斷提高，以及減少資源消耗的必要性，促使企業從傳統的塑膠、金屬和化學品轉向生物基解決方案。對綠色產品的日益關注，刺激了該領域的投資、創新和商業化。因此，永續性主導的需求成為重要的催化劑，為企業拓展業務、開發創新產品和實現全球環境目標鋪平了道路。

與傳統材料的競爭

生物基材料面臨來自傳統塑膠、金屬和化學品的激烈競爭，這些材料憑藉其低成本、可靠的供應鏈和成熟的性能而佔據優勢。許多產業不願輕易轉型，除非生物基替代品能夠提供類似的耐用性、經濟性和擴充性。這種對傳統材料的依賴構成了重大威脅，尤其是在包裝、紡織品和消費品等對成本高度敏感的行業。此外，現有傳統產品的供應商可能會抵制市場變革，進一步阻礙生物基材料的普及。為了應對這些挑戰，生物基材料市場必須專注於技術創新、降低生產成本並推廣永續替代方案的優勢。克服這些障礙對於生物基材料在工業界的廣泛應用至關重要。

新冠疫情的影響：

新冠疫情危機對生物基材料和生物製造市場產生了正面和負面的雙重影響。供應鏈中斷、原料短缺和工廠暫時關閉導致生產放緩，產品上市延遲。經濟情勢的不確定性也為資金籌措和研發活動帶來了挑戰。另一方面，疫情也提高了人們對醫療創新、衛生和永續性的認知，從而推動了對生物工程醫療產品、可生物分解包裝和環保材料的需求。疫情後的復甦工作重點在於加強供應鏈、採用數位化製造解決方案以及強調永續替代方案。因此，儘管新冠疫情暫時阻礙了生產和投資，但它也成為了生物基材料和生物製造領域創新和市場擴張的長期催化劑。

預計在預測期內，生物基塑膠細分市場將成為最大的細分市場。

由於生物基塑膠應用廣泛，涵蓋包裝、消費品、汽車和建築等領域，預計在預測期內，生物基塑膠細分市場將佔據最大的市場佔有率。生物基塑膠的適應性強、環境友好，且能夠取代傳統塑膠，使其成為致力於實現永續性目標的企業的首選。日益增強的環保意識和政府關於減少塑膠使用的法規進一步推動了市場對生物基塑膠的接受度。生物基塑膠在不犧牲性能的前提下，提供了擴充性且經濟高效的解決方案，使各行業能夠同時實現功能性和環境效益。工業需求、監管支持和消費者偏好的共同作用，使得生物基塑膠成為全球生物基材料和生物製造市場的重要組成部分。

預計在預測期內，再生醫療保健產品領域將實現最高的複合年成長率。

預計在預測期內，再生醫療產品領域將實現最高成長率。組織工程、先進傷口護理和標靶藥物遞送系統等應用領域的不斷拓展將推動成長。 3D生物列印、生物支架和生醫材料領域的創新正在推動個人化、高性能醫療解決方案的快速普及。醫療保健支出的成長、對再生醫學日益成長的關注以及政府的支持性政策正在促進投資和商業化前景。對永續和創新療法的需求不斷成長，正在推動市場潛力。技術進步以及不斷變化的醫療保健需求，使再生醫療產品成為全球生物基材料和生物製造市場中成長最快、最具活力的細分市場。

比最大的地區

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其強大的技術基礎設施、強勁的研發實力和廣泛的工業應用。生物基材料的主要生產商集中在該地區，這得益於政府積極的扶持政策和對永續性的重視。醫療保健、包裝、汽車和建築等行業擴大使用生物基材料，以符合環境法規並滿足消費者對環保產品的偏好。對生物製造技術的大規模投資以及人們對永續解決方案日益增強的認知，正在鞏固北美的主導地位。技術實力、監管支援和早期工業應用共同使該地區成為全球生物基材料和生物製造市場的最大貢獻者。

複合年成長率最高的地區：

預計亞太地區在預測期內將呈現最高的複合年成長率。快速的工業發展、永續發展實踐的日益普及以及不斷增強的環保意識正在推動成長。包括中國、印度和日本在內的主要國家正在醫療保健、包裝、建築和汽車行業中擴大採用生物基材料，以實現其環境目標。政府的支持性政策、研發投入以及公私合作進一步推動了市場擴張。消費者對環保產品的需求以及生物製造技術的進步正在促進生物基材料的普及。工業成長、永續性和技術創新相結合，使亞太地區成為全球市場中最具活力和成長最快的地區。

免費客製化服務

訂閱本報告的用戶可享有以下免費客製化服務之一：

公司簡介
- 對至多三家其他市場公司進行全面分析
- 對主要企業進行SWOT分析（最多3家公司）
區域細分
- 根據客戶興趣對主要國家進行市場估算、預測和複合年成長率分析（註：基於可行性檢查）
競爭基準化分析
- 基於產品系列、地域覆蓋和策略聯盟對主要企業基準化分析

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 義大利
- 法國
- 西班牙
- 其他歐洲
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 紐西蘭
- 韓國
- 其他亞太地區
南美洲
- 阿根廷
- 巴西
- 智利
- 南美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 卡達
- 南非
- 其他中東和非洲地區

第10章：重大進展

協議、夥伴關係、合作和合資企業
收購與併購
新產品上市
業務拓展
其他關鍵策略

第11章企業概況

Plastus Biotech
Nordic Bio-Graphite
KalvoTech
Chitelix
BASF
Corbion
Mitsubishi Chemical Corporation
Organovo Holdings Inc.
NatureWorks
DuPont
Braskem
Novamont
BIOME Bioplastics
Arkema
Evonik Industries

簡介目錄圖表

Product Code: SMRC31955

According to Stratistics MRC, the Global Bio-based Materials & Biofabrication Market is accounted for $15.09 billion in 2025 and is expected to reach $33.15 billion by 2032 growing at a CAGR of 11.9% during the forecast period. Bio-based materials and biofabrication are reshaping material development by utilizing renewable biological resources to produce sustainable, efficient products. Extracted from plants, microbes, and natural sources, these materials contribute to environmental preservation through lower emissions and biodegradability. Advanced biofabrication methods, including 3D bioprinting and tissue engineering, facilitate the creation of intricate structures for sectors like healthcare, packaging, and construction. Integrating biology with engineering and materials science is fostering innovative, eco-conscious alternatives to traditional materials. Increasing emphasis on sustainability across industries is fueling investment, research, and practical use of bio-based materials and biofabrication techniques, establishing them as key drivers of the global shift toward greener solutions.

According to the U.S. Department of Agriculture (USDA) BioPreferred Program, over 3,500 bio-based products are certified for federal procurement, spanning lubricants, cleaning agents, plastics, and construction materials. This reflects growing institutional demand for biofabricated alternatives.

Market Dynamics:

Driver:

Growing industrial and healthcare applications

Rising adoption in healthcare and industrial sectors is driving the growth of the bio-based materials and biofabrication market. Healthcare applications, including tissue engineering, regenerative medicine, and controlled drug delivery, are expanding rapidly. Simultaneously, industries such as packaging, construction, and textiles are increasingly using bio-based alternatives to achieve sustainability targets and respond to eco-conscious consumer demand. The materials' biodegradability, functionality, and versatility enhance their appeal across diverse applications. Increased industrial investment, strategic collaborations, and joint research initiatives further promote market expansion. By combining environmental benefits with high performance, bio-based materials and biofabrication are becoming essential across healthcare, manufacturing, and consumer product industries worldwide.

Restraint:

Limited raw material availability

Raw material availability poses a significant challenge for the bio-based materials and biofabrication market. Many materials are sourced from plants, microbes, or other renewable resources, whose supply is subject to seasonal fluctuations, agricultural productivity, and land competition. Limited supply chains and regional dependence can lead to increased costs and production delays. Scaling production to industrial levels may also exert pressure on natural resources, raising sustainability issues. These factors can hinder large-scale manufacturing and slow market expansion. To ensure sustainable growth, reliable, consistent, and environmentally responsible sourcing strategies must be implemented, addressing both supply chain vulnerabilities and the growing industrial demand for bio-based materials and biofabricated products.

Opportunity:

Rising demand for sustainable products

Growing environmental awareness and the push for sustainable practices are creating significant opportunities for bio-based materials and biofabrication. Industries including packaging, healthcare, textiles, and construction are increasingly seeking biodegradable and eco-friendly alternatives, driven by consumer demand and government initiatives. Rising recognition of climate change impacts and the need to reduce resource consumption encourages businesses to shift from traditional plastics, metals, and chemicals to bio-derived solutions. This increasing focus on green products stimulates investment, innovation, and commercialization in the sector. Consequently, sustainability-driven demand acts as a key growth driver, opening avenues for companies to expand their presence, develop innovative offerings, and meet global environmental objectives.

Threat:

Competition from conventional materials

Bio-based materials face strong competition from traditional plastics, metals, and chemicals, which dominate due to lower costs, reliable supply chains, and proven performance. Many industries are reluctant to switch unless bio-derived alternatives offer similar durability, affordability, and scalability. This reliance on conventional materials represents a key threat, particularly in cost-sensitive sectors like packaging, textiles, and consumer goods. Established suppliers of traditional products may also resist market changes, further slowing adoption. To counter this, the bio-based materials market must focus on technological innovation, reducing production costs, and promoting the advantages of sustainable alternatives. Overcoming these barriers is crucial for gaining broader industrial acceptance.

Covid-19 Impact:

The COVID-19 crisis affected the bio-based materials and biofabrication market in both negative and positive ways. Disruptions in supply chains, scarcity of raw materials, and temporary factory closures slowed manufacturing and delayed product rollouts. Funding and research activities also encountered challenges amid economic instability. Conversely, the pandemic increased awareness of healthcare innovations, sanitation, and sustainability, boosting demand for biofabricated medical products, biodegradable packaging, and eco-friendly materials. Recovery efforts post-pandemic have focused on strengthening supply chains, adopting digital manufacturing solutions, and emphasizing sustainable alternatives. Consequently, while COVID-19 temporarily hindered production and investment, it also acted as a long-term catalyst for innovation and market expansion in bio-based materials and biofabrication.

The bio-based plastics segment is expected to be the largest during the forecast period

The bio-based plastics segment is expected to account for the largest market share during the forecast period, driven by their wide-ranging use in packaging, consumer products, automotive, and construction sectors. Their adaptability, eco-friendliness, and capacity to replace traditional plastics make them a preferred choice for companies aiming to meet sustainability targets. Increased environmental awareness and government regulations on plastic reduction have further boosted market adoption. Offering scalable, cost-efficient solutions without compromising performance, bio-based plastics enable industries to achieve both functional and environmental objectives. The combination of industrial demand, regulatory support, and consumer preference establishes bio-based plastics as the leading segment within the global bio-based materials and biofabrication market.

The regenerative healthcare products segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the regenerative healthcare products segment is predicted to witness the highest growth rate. Growth is fueled by expanding applications in tissue engineering, advanced wound care, and targeted drug delivery systems. Innovations in 3D bioprinting, bio-scaffolds, and biomaterials facilitate personalized and high-performance healthcare solutions, driving rapid adoption. Increased healthcare spending, focus on regenerative medicine, and supportive government policies enhance investment and commercialization prospects. Rising demand for sustainable, innovative medical treatments strengthens market potential. Technological progress combined with evolving healthcare requirements positions regenerative healthcare products as the fastest-growing and most dynamic segment in the global bio-based materials and biofabrication market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by robust technological infrastructure, strong research and development activities, and widespread industrial application. Key manufacturers of bio-based materials are concentrated in this region, supported by favorable government initiatives and growing emphasis on sustainability. Sectors including healthcare, packaging, automotive, and construction are increasingly utilizing bio-based materials to comply with environmental regulations and meet consumer preferences for eco-friendly products. Substantial investments in biofabrication technologies and heightened awareness of sustainable solutions reinforce North America's leading position. Technological capabilities, regulatory support, and early adoption by industries collectively make the region the largest contributor to the global bio-based materials and biofabrication market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Growth is fueled by rapid industrial development, increased adoption of sustainable practices, and rising environmental consciousness. Key economies, including China, India, and Japan, are implementing bio-based materials in healthcare, packaging, construction, and automotive industries to achieve environmental targets. Supportive government policies, research investments, and collaboration between public and private sectors further enhance market expansion. Consumer demand for eco-friendly products, along with technological advancements in biofabrication, strengthens adoption. The combination of industrial growth, sustainability initiatives, and innovation positions Asia-Pacific as the most dynamic and fastest-growing region in the global market.

Key players in the market

Some of the key players in Bio-based Materials & Biofabrication Market include Plastus Biotech, Nordic Bio-Graphite, KalvoTech, Chitelix, BASF, Corbion, Mitsubishi Chemical Corporation, Organovo Holdings Inc., NatureWorks, DuPont, Braskem, Novamont, BIOME Bioplastics, Arkema and Evonik Industries.

Key Developments:

In October 2025, BASF SE and ANDRITZ Group have signed a license agreement for the use of BASF's proprietary gas treatment technology, OASE(R) blue, in a carbon capture project planned to be implemented in the city of Aarhus, Denmark. The project aims to capture approximately 435,000 tons of CO2 annually from the flue gases of a waste-to-energy plant for sequestration; the city of Aarhus has set itself the goal of becoming CO2-neutral by 2030.

In August 2025, Corbion and Kuehnle AgroSystems (KAS) have entered into a strategic partnership to develop and commercialize a high-quality, natural astaxanthin derived from non-GMO heterotrophic algae. Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms, including microalgae, salmon, and shrimp. It is widely recognized both for its human health benefits and as a key feed ingredient for salmon and other aquaculture species.

In August 2025, DuPont announced that Arclin has reached a definitive agreement to acquire DuPont's Aramids business in a transaction valuing the business at approximately $1.8 billion. Arclin has received fully committed financing in connection with the transaction, which is expected to close in the first quarter of 2026, subject to customary closing conditions and regulatory approval.

Material Types Covered:

Bio-based Plastics
Bio-based Textiles
Bio-based Composites
Biofabrication Feedstocks

Biofabrication Methods Covered:

3D Bioprinting
Microbial Fermentation
Scaffold-based Tissue Engineering
Scaffold-free Self-assembly

Applications Covered:

Packaging
Fashion & Technical Textiles
Mobility Components
Regenerative Healthcare Products
Sustainable Building Materials
Consumer Lifestyle Products

End Users Covered:

Manufacturing Enterprises
Retail & Brand Owners
Public Sector Institutions
Academic & Research Bodies

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Bio-based Materials & Biofabrication Market, By Material Type

5.1 Introduction
5.2 Bio-based Plastics
5.3 Bio-based Textiles
5.4 Bio-based Composites
5.5 Biofabrication Feedstocks

6 Global Bio-based Materials & Biofabrication Market, By Biofabrication Method

6.1 Introduction
6.2 3D Bioprinting
6.3 Microbial Fermentation
6.4 Scaffold-based Tissue Engineering
6.5 Scaffold-free Self-assembly

7 Global Bio-based Materials & Biofabrication Market, By Application

7.1 Introduction
7.2 Packaging
7.3 Fashion & Technical Textiles
7.4 Mobility Components
7.5 Regenerative Healthcare Products
7.6 Sustainable Building Materials
7.7 Consumer Lifestyle Products

8 Global Bio-based Materials & Biofabrication Market, By End User

8.1 Introduction
8.2 Manufacturing Enterprises
8.3 Retail & Brand Owners
8.4 Public Sector Institutions
8.5 Academic & Research Bodies

9 Global Bio-based Materials & Biofabrication Market, By Geography

9.1 Introduction
9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa

10 Key Developments

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling

11.1 Plastus Biotech
11.2 Nordic Bio-Graphite
11.3 KalvoTech
11.4 Chitelix
11.5 BASF
11.6 Corbion
11.7 Mitsubishi Chemical Corporation
11.8 Organovo Holdings Inc.
11.9 NatureWorks
11.10 DuPont
11.11 Braskem
11.12 Novamont
11.13 BIOME Bioplastics
11.14 Arkema
11.15 Evonik Industries

簡介目錄圖表

List of Tables

Table 1 Global Bio-based Materials & Biofabrication Market Outlook, By Region (2024-2032) ($MN)
Table 2 Global Bio-based Materials & Biofabrication Market Outlook, By Material Type (2024-2032) ($MN)
Table 3 Global Bio-based Materials & Biofabrication Market Outlook, By Bio-based Plastics (2024-2032) ($MN)
Table 4 Global Bio-based Materials & Biofabrication Market Outlook, By Bio-based Textiles (2024-2032) ($MN)
Table 5 Global Bio-based Materials & Biofabrication Market Outlook, By Bio-based Composites (2024-2032) ($MN)
Table 6 Global Bio-based Materials & Biofabrication Market Outlook, By Biofabrication Feedstocks (2024-2032) ($MN)
Table 7 Global Bio-based Materials & Biofabrication Market Outlook, By Biofabrication Method (2024-2032) ($MN)
Table 8 Global Bio-based Materials & Biofabrication Market Outlook, By 3D Bioprinting (2024-2032) ($MN)
Table 9 Global Bio-based Materials & Biofabrication Market Outlook, By Microbial Fermentation (2024-2032) ($MN)
Table 10 Global Bio-based Materials & Biofabrication Market Outlook, By Scaffold-based Tissue Engineering (2024-2032) ($MN)
Table 11 Global Bio-based Materials & Biofabrication Market Outlook, By Scaffold-free Self-assembly (2024-2032) ($MN)
Table 12 Global Bio-based Materials & Biofabrication Market Outlook, By Application (2024-2032) ($MN)
Table 13 Global Bio-based Materials & Biofabrication Market Outlook, By Packaging (2024-2032) ($MN)
Table 14 Global Bio-based Materials & Biofabrication Market Outlook, By Fashion & Technical Textiles (2024-2032) ($MN)
Table 15 Global Bio-based Materials & Biofabrication Market Outlook, By Mobility Components (2024-2032) ($MN)
Table 16 Global Bio-based Materials & Biofabrication Market Outlook, By Regenerative Healthcare Products (2024-2032) ($MN)
Table 17 Global Bio-based Materials & Biofabrication Market Outlook, By Sustainable Building Materials (2024-2032) ($MN)
Table 18 Global Bio-based Materials & Biofabrication Market Outlook, By Consumer Lifestyle Products (2024-2032) ($MN)
Table 19 Global Bio-based Materials & Biofabrication Market Outlook, By End User (2024-2032) ($MN)
Table 20 Global Bio-based Materials & Biofabrication Market Outlook, By Manufacturing Enterprises (2024-2032) ($MN)
Table 21 Global Bio-based Materials & Biofabrication Market Outlook, By Retail & Brand Owners (2024-2032) ($MN)
Table 22 Global Bio-based Materials & Biofabrication Market Outlook, By Public Sector Institutions (2024-2032) ($MN)
Table 23 Global Bio-based Materials & Biofabrication Market Outlook, By Academic & Research Bodies (2024-2032) ($MN)